1-1 of 1
Keywords: Midgut endocrine tumors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study

Available to Purchase
Subject Area:
Endocrinology , Neurology and Neuroscience
Frédérique Maire, Catherine Lombard-Bohas, Dermot O’Toole, Marie-Pierre Vullierme, Vinciane Rebours, Anne Couvelard, Anne Laure Pelletier, Magaly Zappa, Frank Pilleul, Olivia Hentic, Pascal Hammel, Philippe Ruszniewski
Journal: Neuroendocrinology
Neuroendocrinology (2012) 96 (4): 294–300.
https://doi.org/10.1159/000336941
Published Online: 11 April 2012
... was 95%. Grade 3 toxicity occurred in 19% of patients, with no treatment-related deaths and no differences in the treatment arms. Conclusion: HACE and HAE are safe and permit tumor control in 95% of patients with progressive liver metastases from midgut endocrine tumors. The 2-year PFS was not higher...
View articletitled, Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study
Open the PDF for Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study in another window